From Compliance Expert to Convicted Fraudster: The Saga of Jean Wilson

In late June 2026, the Department of Justice (DOJ) announced that the owner of two telemedicine companies was sentenced to 120 months in prison and ordered to pay $66 million in restitution for her role in a Medicare fraud scheme involving durable medical equipment (DME) and prescription drugs. According to DOJ’s press release, Jean Wilson, a licensed nurse practitioner from Richmond Hill, Georgia, owned and operated two telemedicine companies that generated medically unnecessary orders for orthotic braces and prescriptions for Medicare beneficiaries.

In addition to owning the telemedicine companies, Wilson held herself out as a “Medical Professional Legal Consultant” and authored books on health care compliance, even after her arrest and indictment. According to the DOJ’s press release, Wilson authored multiple books on health care compliance, including one called “Avoiding Health Care Pitfalls,” where she warned that “Some entities and individuals will try to use you as a way to make them millions!”

The DOJ alleged that Wilson and others (including her husband who was previously sentenced to 7 years in prison) paid illegal kickbacks to medical providers to sign orders for braces and prescriptions even though the beneficiaries did not need them. Wilson also signed many prescriptions herself. The orders and prescriptions were then sold to marketing companies for approximately $90 per Medicare beneficiary. Those companies allegedly resold the orders to brace companies and pharmacies, which submitted claims to Medicare.

The government alleged that the scheme resulted in more than $136 million in false and fraudulent claims to Medicare, of which Medicare paid more than $66 million. Wilson pleaded guilty in March 2024.

The case reflects the DOJ’s continued focus on telemedicine arrangements, DME orders, and marketing arrangements. These cases often involve the same basic enforcement themes: patient leads generated through marketing, brief or questionable telehealth encounters, preloaded or templated orders, compensation tied to the volume of signed orders, and downstream billing by DME suppliers.

For providers, the key lesson is that telemedicine does not change the underlying compliance rules. A practitioner must still establish medical necessity, document the basis for the order, and ensure that compensation arrangements do not reward referrals or the generation of reimbursable items or services. The fact that a patient encounter occurs remotely does not insulate the provider from scrutiny.

Health care providers should be cautious before entering into telemedicine, DME, laboratory, pharmacy, or marketing arrangements that promise easy revenue or require little patient interaction. Red flags may include payments tied to signed orders, marketers controlling patient flow, limited documentation, orders for multiple braces or products without individualized need, or pressure to approve high volumes of prescriptions or DME items.

Providers should also remember that enforcement risk is not limited to the companies submitting claims. Physicians, nurse practitioners, physician assistants, marketers, owners, investors, and billing entities can all become targets depending on their role in the arrangement.

GWB represents healthcare providers in connection with government investigations and litigation. If you need assistance with such a matter, contact us today.